|  Help  |  About  |  Contact Us

Search our database by keyword

- or -

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 601 to 700 out of 1351 for Arpp21

Category restricted to Publication (x)

<< First    < Previous  |  Next >    Last >>
0.035s

Categories

Category: Publication
« show all
Type Details Score
Publication
28740553 | J:350778
First Author: Liang XG
Year: 2017
Journal: Theranostics
Title: A Fluorogenic Probe for Ultrafast and Reversible Detection of Formaldehyde in Neurovascular Tissues.
Volume: 7
Issue: 8
Pages: 2305-2313
•
•
•
•
•
Publication
27318146 | J:239036
 
First Author: Rosen RF
Year: 2016
Journal: Neurobiol Aging
Title: Comparative pathobiology of β-amyloid and the unique susceptibility of humans to Alzheimer's disease.
Volume: 44
Pages: 185-196
•
•
•
•
•
Publication
23512986 | J:198545
First Author: Xu G
Year: 2013
Journal: Hum Mol Genet
Title: Cytosolic proteins lose solubility as amyloid deposits in a transgenic mouse model of Alzheimer-type amyloidosis.
Volume: 22
Issue: 14
Pages: 2765-74
•
•
•
•
•
Publication
37446867 | J:350754
 
First Author: Gagnon M
Year: 2023
Journal: Molecules
Title: Evaluation of Novel B1R/B2R Agonists Containing TRIOZAN™ Nanoparticles for Targeted Brain Delivery of Antibodies in a Mouse Model of Alzheimer Disease.
Volume: 28
Issue: 13
•
•
•
•
•
Publication
30240904 | J:352117
 
First Author: Massimi L
Year: 2019
Journal: Neuroimage
Title: Exploring Alzheimer's disease mouse brain through X-ray phase contrast tomography: From the cell to the organ.
Volume: 184
Pages: 490-495
•
•
•
•
•
Publication
30068274 | J:352112
First Author: Manocha G
Year: 2018
Journal: Curr Alzheimer Res
Title: Anti-α4β1 Integrin Antibodies Attenuated Brain Inflammatory Changes in a Mouse Model of Alzheimer's Disease.
Volume: 15
Issue: 12
Pages: 1123-1135
•
•
•
•
•
Publication
30074800 | J:352113
First Author: Pan Y
Year: 2018
Journal: Mol Pharm
Title: Altered Expression of Small Intestinal Drug Transporters and Hepatic Metabolic Enzymes in a Mouse Model of Familial Alzheimer's Disease.
Volume: 15
Issue: 9
Pages: 4073-4083
•
•
•
•
•
Publication
30252487 | J:352118
First Author: Chang R
Year: 2018
Journal: Mol Pharm
Title: Brain Penetrating Bifunctional Erythropoietin-Transferrin Receptor Antibody Fusion Protein for Alzheimer's Disease.
Volume: 15
Issue: 11
Pages: 4963-4973
•
•
•
•
•
Publication
16169151 | J:104569
First Author: Lalonde R
Year: 2005
Journal: Neurosci Lett
Title: Exploratory activity and spatial learning in 12-month-old APP(695)SWE/co+PS1/DeltaE9 mice with amyloid plaques.
Volume: 390
Issue: 2
Pages: 87-92
•
•
•
•
•
Publication
29449587 | J:262675
First Author: Cai H
Year: 2018
Journal: Sci Rep
Title: The Mechanisms of Bushen-Yizhi Formula as a Therapeutic Agent against Alzheimer's Disease.
Volume: 8
Issue: 1
Pages: 3104
•
•
•
•
•
Publication
25031402 | J:348875
First Author: Xiao Q
Year: 2014
Journal: J Neurosci
Title: Enhancing astrocytic lysosome biogenesis facilitates Aβ clearance and attenuates amyloid plaque pathogenesis.
Volume: 34
Issue: 29
Pages: 9607-20
•
•
•
•
•
Publication
27344237 | J:256813
First Author: Abad S
Year: 2016
Journal: Biochim Biophys Acta
Title: Adolescent exposure to MDMA induces dopaminergic toxicity in substantia nigra and potentiates the amyloid plaque deposition in the striatum of APPswe/PS1dE9 mice.
Volume: 1862
Issue: 9
Pages: 1815-26
•
•
•
•
•
Publication
33634529 | J:308491
First Author: Smit T
Year: 2021
Journal: Glia
Title: Reactive astrocytes as treatment targets in Alzheimer's disease-Systematic review of studies using the APPswePS1dE9 mouse model.
Volume: 69
Issue: 8
Pages: 1852-1881
•
•
•
•
•
Publication
25319699 | J:348876
First Author: Balducci C
Year: 2014
Journal: J Neurosci
Title: Multifunctional liposomes reduce brain β-amyloid burden and ameliorate memory impairment in Alzheimer's disease mouse models.
Volume: 34
Issue: 42
Pages: 14022-31
•
•
•
•
•
Publication
26338325 | J:348878
First Author: Xiao Q
Year: 2015
Journal: J Neurosci
Title: Neuronal-Targeted TFEB Accelerates Lysosomal Degradation of APP, Reducing Aβ Generation and Amyloid Plaque Pathogenesis.
Volume: 35
Issue: 35
Pages: 12137-51
•
•
•
•
•
Publication
39030247 | J:352142
First Author: Aishwarya R
Year: 2024
Journal: Sci Rep
Title: Diastolic dysfunction in Alzheimer's disease model mice is associated with Aβ-amyloid aggregate formation and mitochondrial dysfunction.
Volume: 14
Issue: 1
Pages: 16715
•
•
•
•
•
Publication
22227002 | J:182319
First Author: Hsiao YH
Year: 2012
Journal: Neurobiol Dis
Title: Amelioration of social isolation-triggered onset of early Alzheimer's disease-related cognitive deficit by N-acetylcysteine in a transgenic mouse model.
Volume: 45
Issue: 3
Pages: 1111-20
•
•
•
•
•
Publication
22230888 | J:182316
First Author: Poirier R
Year: 2012
Journal: Neurosci Lett
Title: Early brain amyloidosis in APP/PS1 mice with serum insulin-like growth factor-I deficiency.
Volume: 509
Issue: 2
Pages: 101-4
•
•
•
•
•
Publication
29056359 | J:262115
First Author: Ruan CS
Year: 2018
Journal: Exp Neurol
Title: Sortilin inhibits amyloid pathology by regulating non-specific degradation of APP.
Volume: 299
Issue: Pt A
Pages: 75-85
•
•
•
•
•
Publication
28964771 | J:252534
 
First Author: Wang L
Year: 2017
Journal: Neurosci Lett
Title: The cytoplasmic nuclear shuttling of Beclin 1 in neurons with Alzheimer's disease-like injury.
Volume: 661
Pages: 63-70
•
•
•
•
•
Publication
24892886 | J:214745
 
First Author: Wang R
Year: 2014
Journal: Neurobiol Dis
Title: RanBP9 overexpression accelerates loss of dendritic spines in a mouse model of Alzheimer's disease.
Volume: 69
Pages: 169-79
•
•
•
•
•
Publication
24332448 | J:212731
First Author: Huang XT
Year: 2014
Journal: Neurobiol Aging
Title: Reducing iron in the brain: a novel pharmacologic mechanism of huperzine A in the treatment of Alzheimer's disease.
Volume: 35
Issue: 5
Pages: 1045-54
•
•
•
•
•
Publication
32670047 | J:291504
 
First Author: Feng C
Year: 2020
Journal: Front Aging Neurosci
Title: Calcium-Sensing Receptor Mediates β-Amyloid-Induced Synaptic Formation Impairment and Cognitive Deficits via Regulation of Cytosolic Phospholipase A2/Prostaglandin E2 Metabolic Pathway.
Volume: 12
Pages: 144
•
•
•
•
•
Publication
23651058 | J:202644
First Author: Ostapchenko VG
Year: 2013
Journal: J Neurochem
Title: Increased prion protein processing and expression of metabotropic glutamate receptor 1 in a mouse model of Alzheimer's disease.
Volume: 127
Issue: 3
Pages: 415-25
•
•
•
•
•
Publication
34112929 | J:308484
First Author: Guillot-Sestier MV
Year: 2021
Journal: Commun Biol
Title: Microglial metabolism is a pivotal factor in sexual dimorphism in Alzheimer's disease.
Volume: 4
Issue: 1
Pages: 711
•
•
•
•
•
Publication
24210253 | J:212742
First Author: Zerbi V
Year: 2014
Journal: Neurobiol Aging
Title: Multinutrient diets improve cerebral perfusion and neuroprotection in a murine model of Alzheimer's disease.
Volume: 35
Issue: 3
Pages: 600-13
•
•
•
•
•
Publication
26022183 | J:350793
First Author: Lin Z
Year: 2015
Journal: Neurodegener Dis
Title: Downregulation of β-Soluble N-Ethylmaleimide-Sensitive Factor Attachment Protein: Proteomics-Based Identification in Early-Stage Prion Disease.
Volume: 15
Issue: 4
Pages: 193-201
•
•
•
•
•
Publication
24964199 | J:216819
First Author: Sung HY
Year: 2014
Journal: PLoS One
Title: Amyloid beta-mediated epigenetic alteration of insulin-like growth factor binding protein 3 controls cell survival in Alzheimer's disease.
Volume: 9
Issue: 6
Pages: e99047
•
•
•
•
•
Publication
36182964 | J:334767
First Author: Jana A
Year: 2022
Journal: Sci Rep
Title: Increased Type I interferon signaling and brain endothelial barrier dysfunction in an experimental model of Alzheimer's disease.
Volume: 12
Issue: 1
Pages: 16488
•
•
•
•
•
Publication
22560596 | J:186448
 
First Author: Wang Q
Year: 2012
Journal: Brain Res
Title: Stromal cell-derived factor 1α decreases β-amyloid deposition in Alzheimer's disease mouse model.
Volume: 1459
Pages: 15-26
•
•
•
•
•
Publication
36535550 | J:332417
 
First Author: Day SM
Year: 2022
Journal: Neurobiol Dis
Title: Ethanol exposure alters Alzheimer's-related pathology, behavior, and metabolism in APP/PS1 mice.
Volume: 177
Pages: 105967
•
•
•
•
•
Publication
34326412 | J:311394
First Author: de Veij Mestdagh CF
Year: 2021
Journal: Sci Rep
Title: Torpor enhances synaptic strength and restores memory performance in a mouse model of Alzheimer's disease.
Volume: 11
Issue: 1
Pages: 15486
•
•
•
•
•
Publication
27240542 | J:255668
First Author: Song N
Year: 2016
Journal: Biochim Biophys Acta
Title: Cyanidin 3-O-β-glucopyranoside activates peroxisome proliferator-activated receptor-γ and alleviates cognitive impairment in the APP(swe)/PS1(ΔE9) mouse model.
Volume: 1862
Issue: 9
Pages: 1786-800
•
•
•
•
•
Publication
29050859 | J:269795
 
First Author: Tai J
Year: 2018
Journal: Brain Res
Title: Neuroprotective effects of a triple GLP-1/GIP/glucagon receptor agonist in the APP/PS1 transgenic mouse model of Alzheimer's disease.
Volume: 1678
Pages: 64-74
•
•
•
•
•
Publication
20624932 | J:196634
First Author: Kim MJ
Year: 2010
Journal: FASEB J
Title: Glutamate carboxypeptidase II: an amyloid peptide-degrading enzyme with physiological function in the brain.
Volume: 24
Issue: 11
Pages: 4491-502
•
•
•
•
•
Publication
27641666 | J:239130
First Author: Go M
Year: 2016
Journal: Biochem Biophys Res Commun
Title: Microglial response to LPS increases in wild-type mice during aging but diminishes in an Alzheimer's mouse model: Implication of TLR4 signaling in disease progression.
Volume: 479
Issue: 2
Pages: 331-337
•
•
•
•
•
Publication
31831179 | J:291814
First Author: Wang M
Year: 2020
Journal: Biochem Biophys Res Commun
Title: Mid infrared light treatment attenuates cognitive decline and alters the gut microbiota community in APP/PS1 mouse model.
Volume: 523
Issue: 1
Pages: 60-65
•
•
•
•
•
Publication
25912481 | J:256891
 
First Author: Matsumura A
Year: 2015
Journal: Free Radic Biol Med
Title: Evaluation of oxidative stress in the brain of a transgenic mouse model of Alzheimer disease by in vivo electron paramagnetic resonance imaging.
Volume: 85
Pages: 165-73
•
•
•
•
•
Publication
35846991 | J:342249
 
First Author: Chen CL
Year: 2022
Journal: Front Pharmacol
Title: Prominent Effects of Berbamine Hydrochloride on Alzheimer's Disease Model Mice.
Volume: 13
Pages: 939039
•
•
•
•
•
Publication
37079191 | J:348856
First Author: Mahaman YAR
Year: 2023
Journal: Neurotherapeutics
Title: Ferulic Acid Improves Synaptic Plasticity and Cognitive Impairments by Alleviating the PP2B/DARPP-32/PP1 Axis-Mediated STEP Increase and Aβ Burden in Alzheimer's Disease.
Volume: 20
Issue: 4
Pages: 1081-1108
•
•
•
•
•
Publication
29922152 | J:276664
 
First Author: Yang W
Year: 2018
Journal: Front Aging Neurosci
Title: Naringin Dihydrochalcone Ameliorates Cognitive Deficits and Neuropathology in APP/PS1 Transgenic Mice.
Volume: 10
Pages: 169
•
•
•
•
•
Publication
25938784 | J:222966
First Author: Macauley SL
Year: 2015
Journal: J Clin Invest
Title: Hyperglycemia modulates extracellular amyloid-β concentrations and neuronal activity in vivo.
Volume: 125
Issue: 6
Pages: 2463-7
•
•
•
•
•
Publication
37919286 | J:342269
First Author: Shoob S
Year: 2023
Journal: Nat Commun
Title: Deep brain stimulation of thalamic nucleus reuniens promotes neuronal and cognitive resilience in an Alzheimer's disease mouse model.
Volume: 14
Issue: 1
Pages: 7002
•
•
•
•
•
Publication
32706773 | J:291860
First Author: Tanaka N
Year: 2020
Journal: PLoS One
Title: Development of a brain-permeable peptide nanofiber that prevents aggregation of Alzheimer pathogenic proteins.
Volume: 15
Issue: 7
Pages: e0235979
•
•
•
•
•
Publication
22539346 | J:186509
First Author: Xiao Q
Year: 2012
Journal: J Biol Chem
Title: Role of phosphatidylinositol clathrin assembly lymphoid-myeloid leukemia (PICALM) in intracellular amyloid precursor protein (APP) processing and amyloid plaque pathogenesis.
Volume: 287
Issue: 25
Pages: 21279-89
•
•
•
•
•
Publication
29222348 | J:272127
 
First Author: Li H
Year: 2018
Journal: Biosci Rep
Title: Insulin degrading enzyme contributes to the pathology in a mixed model of Type 2 diabetes and Alzheimer's disease: possible mechanisms of IDE in T2D and AD.
Volume: 38
Issue: 1
•
•
•
•
•
Publication
24499794 | J:296285
First Author: Choi KJ
Year: 2014
Journal: J Biosci
Title: Three-dimensional analysis of abnormal ultrastructural alteration in mitochondria of hippocampus of APP/PSEN1 transgenic mouse.
Volume: 39
Issue: 1
Pages: 97-105
•
•
•
•
•
Publication
28771808 | J:272128
First Author: Li H
Year: 2018
Journal: J Cell Biochem
Title: cAMP/PKA signaling pathway contributes to neuronal apoptosis via regulating IDE expression in a mixed model of type 2 diabetes and Alzheimer's disease.
Volume: 119
Issue: 2
Pages: 1616-1626
•
•
•
•
•
Publication
39026992 | J:352237
 
First Author: Wang J
Year: 2024
Journal: Front Aging Neurosci
Title: ACOT7, a candidate and novel serum biomarker of Alzheimer's disease.
Volume: 16
Pages: 1345668
•
•
•
•
•
Publication
24792906 | J:214853
First Author: Kellner V
Year: 2014
Journal: Neurobiol Aging
Title: Amyloid-β alters ongoing neuronal activity and excitability in the frontal cortex.
Volume: 35
Issue: 9
Pages: 1982-91
•
•
•
•
•
Publication
20005821 | J:155809
First Author: Kim J
Year: 2009
Journal: Neuron
Title: Overexpression of low-density lipoprotein receptor in the brain markedly inhibits amyloid deposition and increases extracellular A beta clearance.
Volume: 64
Issue: 5
Pages: 632-44
•
•
•
•
•
Publication
28377712 | J:276678
 
First Author: Xia DY
Year: 2017
Journal: Front Aging Neurosci
Title: PGC-1α or FNDC5 Is Involved in Modulating the Effects of Aβ1-42 Oligomers on Suppressing the Expression of BDNF, a Beneficial Factor for Inhibiting Neuronal Apoptosis, Aβ Deposition and Cognitive Decline of APP/PS1 Tg Mice.
Volume: 9
Pages: 65
•
•
•
•
•
Publication
28603494 | J:275603
 
First Author: Wang X
Year: 2017
Journal: Front Aging Neurosci
Title: YXQN Reduces Alzheimer's Disease-Like Pathology and Cognitive Decline in APPswePS1dE9 Transgenic Mice.
Volume: 9
Pages: 157
•
•
•
•
•
Publication
24155308 | J:204673
First Author: Xie H
Year: 2013
Journal: J Neurosci
Title: Mitochondrial alterations near amyloid plaques in an Alzheimer's disease mouse model.
Volume: 33
Issue: 43
Pages: 17042-51
•
•
•
•
•
Publication
21513747 | J:172201
First Author: Zhang W
Year: 2011
Journal: Behav Brain Res
Title: Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
Volume: 222
Issue: 2
Pages: 342-50
•
•
•
•
•
Publication
19625507 | J:151798
First Author: Shi Q
Year: 2009
Journal: J Neurosci
Title: Reduced amyloid deposition in mice overexpressing RTN3 is adversely affected by preformed dystrophic neurites.
Volume: 29
Issue: 29
Pages: 9163-73
•
•
•
•
•
Publication
36937050 | J:345219
 
First Author: Tian Y
Year: 2023
Journal: Front Mol Neurosci
Title: The role of ADAM17 in cerebrovascular and cognitive function in the APP/PS1 mouse model of Alzheimer's disease.
Volume: 16
Pages: 1125932
•
•
•
•
•
Publication
32265655 | J:311662
 
First Author: Flores-Muñoz C
Year: 2020
Journal: Front Cell Neurosci
Title: Acute Pannexin 1 Blockade Mitigates Early Synaptic Plasticity Defects in a Mouse Model of Alzheimer's Disease.
Volume: 14
Pages: 46
•
•
•
•
•
Publication
22219198 | J:182430
First Author: Mori T
Year: 2012
Journal: J Biol Chem
Title: Tannic acid is a natural β-secretase inhibitor that prevents cognitive impairment and mitigates Alzheimer-like pathology in transgenic mice.
Volume: 287
Issue: 9
Pages: 6912-27
•
•
•
•
•
Publication
27903721 | J:237190
First Author: Ledo JH
Year: 2016
Journal: J Neurosci
Title: Cross Talk Between Brain Innate Immunity and Serotonin Signaling Underlies Depressive-Like Behavior Induced by Alzheimer's Amyloid-β Oligomers in Mice.
Volume: 36
Issue: 48
Pages: 12106-12116
•
•
•
•
•
Publication
36975362 | J:353673
First Author: Lemaitre P
Year: 2023
Journal: EMBO Mol Med
Title: Molecular and cognitive signatures of ageing partially restored through synthetic delivery of IL2 to the brain.
Volume: 15
Issue: 5
Pages: e16805
•
•
•
•
•
Publication
29293211 | J:334848
First Author: Venegas C
Year: 2017
Journal: Nature
Title: Microglia-derived ASC specks cross-seed amyloid-β in Alzheimer's disease.
Volume: 552
Issue: 7685
Pages: 355-361
•
•
•
•
•
Publication
29844346 | J:263099
First Author: Song M
Year: 2018
Journal: Sci Rep
Title: Classification of Spatiotemporal Neural Activity Patterns in Brain Imaging Data.
Volume: 8
Issue: 1
Pages: 8231
•
•
•
•
•
Publication
36819109 | J:337529
 
First Author: Das S
Year: 2023
Journal: Front Cell Dev Biol
Title: Region-specific heterogeneity in neuronal nuclear morphology in young, aged and in Alzheimer's disease mouse brains.
Volume: 11
Pages: 1032504
•
•
•
•
•
Publication
20053373 | J:159939
First Author: Machová E
Year: 2010
Journal: Neurobiol Dis
Title: Functional cholinergic damage develops with amyloid accumulation in young adult APPswe/PS1dE9 transgenic mice.
Volume: 38
Issue: 1
Pages: 27-35
•
•
•
•
•
Publication
33153499 | J:311733
First Author: Kim SH
Year: 2020
Journal: Acta Neuropathol Commun
Title: Cerebral amyloid angiopathy aggravates perivascular clearance impairment in an Alzheimer's disease mouse model.
Volume: 8
Issue: 1
Pages: 181
•
•
•
•
•
Publication
31150388 | J:276728
First Author: Onos KD
Year: 2019
Journal: PLoS Genet
Title: Enhancing face validity of mouse models of Alzheimer's disease with natural genetic variation.
Volume: 15
Issue: 5
Pages: e1008155
•
•
•
•
•
Publication
32999398 | J:296341
First Author: Badachhape AA
Year: 2020
Journal: Sci Rep
Title: Pre-clinical dose-ranging efficacy, pharmacokinetics, tissue biodistribution, and toxicity of a targeted contrast agent for MRI of amyloid deposition in Alzheimer's disease.
Volume: 10
Issue: 1
Pages: 16185
•
•
•
•
•
Publication
28597477 | J:272157
First Author: Liu Y
Year: 2017
Journal: CNS Neurosci Ther
Title: Effective expression of Drebrin in hippocampus improves cognitive function and alleviates lesions of Alzheimer's disease in APP (swe)/PS1 (ΔE9) mice.
Volume: 23
Issue: 7
Pages: 590-604
•
•
•
•
•
Publication
19812338 | J:153880
First Author: Meyer-Luehmann M
Year: 2009
Journal: J Neurosci
Title: A reporter of local dendritic translocation shows plaque- related loss of neural system function in APP-transgenic mice.
Volume: 29
Issue: 40
Pages: 12636-40
•
•
•
•
•
Publication
22771768 | J:192673
 
First Author: Sierksma AS
Year: 2013
Journal: Neuropharmacology
Title: Chronic phosphodiesterase type 2 inhibition improves memory in the APPswe/PS1dE9 mouse model of Alzheimer's disease.
Volume: 64
Pages: 124-36
•
•
•
•
•
Publication
32771067 | J:311715
First Author: Michael J
Year: 2020
Journal: Acta Neuropathol Commun
Title: Microglia depletion diminishes key elements of the leukotriene pathway in the brain of Alzheimer's Disease mice.
Volume: 8
Issue: 1
Pages: 129
•
•
•
•
•
Publication
27059136 | J:235191
First Author: Toba J
Year: 2016
Journal: Biochem Biophys Res Commun
Title: PPARγ agonist pioglitazone improves cerebellar dysfunction at pre-Aβ deposition stage in APPswe/PS1dE9 Alzheimer's disease model mice.
Volume: 473
Issue: 4
Pages: 1039-1044
•
•
•
•
•
Publication
35671859 | J:327301
 
First Author: Li T
Year: 2022
Journal: Prog Neurobiol
Title: Ube2c-inhibition alleviated amyloid pathology and memory deficits in APP/PS1 mice model of AD.
Volume: 215
Pages: 102298
•
•
•
•
•
Publication
28114405 | J:247965
First Author: Kastanenka KV
Year: 2017
Journal: PLoS One
Title: Optogenetic Restoration of Disrupted Slow Oscillations Halts Amyloid Deposition and Restores Calcium Homeostasis in an Animal Model of Alzheimer's Disease.
Volume: 12
Issue: 1
Pages: e0170275
•
•
•
•
•
Publication
37935829 | J:342414
First Author: Ribeiro FC
Year: 2023
Journal: Commun Biol
Title: Synaptic proteasome is inhibited in Alzheimer's disease models and associates with memory impairment in mice.
Volume: 6
Issue: 1
Pages: 1127
•
•
•
•
•
Publication
32860886 | J:299161
 
First Author: Zhang W
Year: 2020
Journal: Neurosci Lett
Title: FoxO1 overexpression reduces Aβ production and tau phosphorylation in vitro.
Volume: 738
Pages: 135322
•
•
•
•
•
Publication
25975173 | J:227149
 
First Author: Kemppainen S
Year: 2015
Journal: Behav Brain Res
Title: Cerebral dopamine neurotrophic factor improves long-term memory in APP/PS1 transgenic mice modeling Alzheimer's disease as well as in wild-type mice.
Volume: 291
Pages: 1-11
•
•
•
•
•
Publication
30596517 | J:288812
First Author: Wang T
Year: 2019
Journal: FASEB J
Title: BAP31 deficiency contributes to the formation of amyloid-β plaques in Alzheimer's disease by reducing the stability of RTN3.
Volume: 33
Issue: 4
Pages: 4936-4946
•
•
•
•
•
Publication
28287086 | J:244385
 
First Author: Klementieva O
Year: 2017
Journal: Nat Commun
Title: Pre-plaque conformational changes in Alzheimer's disease-linked Aβ and APP.
Volume: 8
Pages: 14726
•
•
•
•
•
Publication
19449368 | J:151904
First Author: Knafo S
Year: 2009
Journal: J Pathol
Title: Morphological alterations to neurons of the amygdala and impaired fear conditioning in a transgenic mouse model of Alzheimer's disease.
Volume: 219
Issue: 1
Pages: 41-51
•
•
•
•
•
Publication
34650426 | J:312659
 
First Author: Zheng R
Year: 2021
Journal: Front Pharmacol
Title: Xueshuantong Improves Functions of Lymphatic Ducts and Modulates Inflammatory Responses in Alzheimer's Disease Mice.
Volume: 12
Pages: 605814
•
•
•
•
•
Publication
17916337 | J:127348
 
First Author: Hooijmans CR
Year: 2007
Journal: Brain Res
Title: Amyloid beta deposition is related to decreased glucose transporter-1 levels and hippocampal atrophy in brains of aged APP/PS1 mice.
Volume: 1181
Pages: 93-103
•
•
•
•
•
Publication
29426890 | J:263124
First Author: Liu H
Year: 2018
Journal: Sci Rep
Title: Guanosine monophosphate reductase 1 is a potential therapeutic target for Alzheimer's disease.
Volume: 8
Issue: 1
Pages: 2759
•
•
•
•
•
Publication
23107435 | J:214932
First Author: Zhu X
Year: 2013
Journal: Aging Cell
Title: Hopeahainol A attenuates memory deficits by targeting β-amyloid in APP/PS1 transgenic mice.
Volume: 12
Issue: 1
Pages: 85-92
•
•
•
•
•
Publication
32879385 | J:296403
First Author: Hascup KN
Year: 2020
Journal: Sci Rep
Title: Hippocampal alterations in glutamatergic signaling during amyloid progression in AβPP/PS1 mice.
Volume: 10
Issue: 1
Pages: 14503
•
•
•
•
•
Publication
37166426 | J:349109
First Author: Cheng CH
Year: 2023
Journal: Aging (Albany NY)
Title: Plasmon-activated water as a therapeutic strategy in Alzheimer's disease by altering gut microbiota.
Volume: 15
Issue: 9
Pages: 3715-3737
•
•
•
•
•
Publication
22476196 | J:184539
First Author: Bomfim TR
Year: 2012
Journal: J Clin Invest
Title: An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease- associated Aβ oligomers.
Volume: 122
Issue: 4
Pages: 1339-53
•
•
•
•
•
Publication
20595388 | J:166179
First Author: Liang B
Year: 2010
Journal: J Biol Chem
Title: Calpain activation promotes BACE1 expression, amyloid precursor protein processing, and amyloid plaque formation in a transgenic mouse model of Alzheimer disease.
Volume: 285
Issue: 36
Pages: 27737-44
•
•
•
•
•
Publication
37838248 | J:342435
 
First Author: Wong D
Year: 2024
Journal: Behav Brain Res
Title: Magnetic resonance spectroscopy in the hippocampus of adult APP/PS1 mice following chronic vitamin D deficiency.
Volume: 457
Pages: 114713
•
•
•
•
•
Publication
28108292 | J:260942
 
First Author: Walker JM
Year: 2017
Journal: Neurobiol Dis
Title: Reversal of high fat diet-induced obesity improves glucose tolerance, inflammatory response, β-amyloid accumulation and cognitive decline in the APP/PSEN1 mouse model of Alzheimer's disease.
Volume: 100
Pages: 87-98
•
•
•
•
•
Publication
28598849 | J:271900
First Author: Adegoke OO
Year: 2017
Journal: J Alzheimers Dis
Title: Overexpression of Ubiquilin-1 Alleviates Alzheimer's Disease-Caused Cognitive and Motor Deficits and Reduces Amyloid-β Accumulation in Mice.
Volume: 59
Issue: 2
Pages: 575-590
•
•
•
•
•
Publication
31941827 | J:285209
 
First Author: Zhang F
Year: 2020
Journal: Sci Transl Med
Title: β-amyloid redirects norepinephrine signaling to activate the pathogenic GSK3β/tau cascade.
Volume: 12
Issue: 526
•
•
•
•
•
Publication
39541211 | J:359541
First Author: Cankar N
Year: 2024
Journal: Cell Rep
Title: Sleep deprivation leads to non-adaptive alterations in sleep microarchitecture and amyloid-β accumulation in a murine Alzheimer model.
Volume: 43
Issue: 11
Pages: 114977
•
•
•
•
•
Publication
28904096 | J:256928
First Author: Ofengeim D
Year: 2017
Journal: Proc Natl Acad Sci U S A
Title: RIPK1 mediates a disease-associated microglial response in Alzheimer's disease.
Volume: 114
Issue: 41
Pages: E8788-E8797
•
•
•
•
•
Publication
23741496 | J:200782
First Author: Bosomworth HJ
Year: 2013
Journal: PLoS One
Title: Altered expression of ZnT10 in Alzheimer's disease brain.
Volume: 8
Issue: 5
Pages: e65475
•
•
•
•
•
Publication
38724485 | J:359547
First Author: Sin YY
Year: 2024
Journal: FEBS Lett
Title: Beta-amyloid interacts with and activates the long-form phosphodiesterase PDE4D5 in neuronal cells to reduce cAMP availability.
Volume: 598
Issue: 13
Pages: 1591-1604
•
•
•
•
•
Publication
34671235 | J:312678
 
First Author: Willuweit A
Year: 2021
Journal: Front Neurosci
Title: Comparison of the Amyloid Load in the Brains of Two Transgenic Alzheimer's Disease Mouse Models Quantified by Florbetaben Positron Emission Tomography.
Volume: 15
Pages: 699926
•
•
•
•
•
Publication
18716656 | J:139681
First Author: Yoshiike Y
Year: 2008
Journal: PLoS One
Title: GABA(A) receptor-mediated acceleration of aging-associated memory decline in APP/PS1 mice and its pharmacological treatment by picrotoxin.
Volume: 3
Issue: 8
Pages: e3029
•
•
•
•
•
Publication
34681766 | J:313681
 
First Author: Alfaro-Ruiz R
Year: 2021
Journal: Int J Mol Sci
Title: The Expression and Localisation of G-Protein-Coupled Inwardly Rectifying Potassium (GIRK) Channels Is Differentially Altered in the Hippocampus of Two Mouse Models of Alzheimer's Disease.
Volume: 22
Issue: 20
•
•
•
•
•




MouseMine is a collaboration between MGI at The Jackson Laboratory and the InterMine project at the Cambridge Systems Biology Centre. MouseMine is funded through a grant from the NIH/NHGRI.The Jackson Laboratory makes no representation about the suitability or accuracy of this software or data for any purpose, and makes no warranties, either express or implied, including merchantability and fitness for a particular purpose or that the use of this software or data will not infringe any third party patents, copyrights, trademarks, or other rights. the software and data are provided "as is". This software and data are provided to enhance knowledge and encourage progress in the scientific community and are to be used only for research and educational purposes. Any reproduction or use for commercial purpose is prohibited without the prior express written permission of the Jackson Laboratory.

Copyright © 2017 by The Jackson Laboratory. All Rights Reserved

© 2002 - 2017 Department of Genetics, University of Cambridge, Downing Street,
Cambridge CB2 3EH, United Kingdom